Skip to main content
Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it.
Approach to the patient: transgender youth: endocrine considerations.
Use of aromatase inhibitors in large cell calcifying sertoli cell tumors: effects on gynecomastia, growth velocity, and bone age.
Quantitation of CYP24A1 enzymatic activity with a simple two-hybrid system.
Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient.
Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation.
Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implications.
Cortisol response to operative stress with anesthesia in healthy children.
Clinical review: kinase inhibitors: adverse effects related to the endocrine system.
Varied clinical presentations of seven patients with mutations in CYP11A1 encoding the cholesterol side-chain cleavage enzyme, P450scc.